PharmaCyte Biotech Aktie 112614797 / US71715X2036
1.50
USD
-0.11
USD
-6.83%
07.02.2025
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
PharmaCyte Biotech Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2023 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2022 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2021 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2020 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2019 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2018 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2017 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2016 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
| 2015 | PharmaCyte Biotech Inc Registered Shs | 0.00 | 0.00 | USD |
Zu diesem Datensatz liegen uns leider keine Daten vor.
PharmaCyte Biotech Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|
PharmaCyte Biotech Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Hauptversammlung | Annual General Meeting | 29.04.2024 |
| Hauptversammlung | Annual General Meeting | 28.12.2022 |
| Quartalszahlen | Q3 2022 Earnings Release | 16.03.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 15.12.2021 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 89.47 |
| Intracoastal Capital LLC | 7.57 |
| The K2 Principal Fund LP | 3.00 |
| Vanguard Group, Inc. (Subfiler) | 2.76 |
| Iroquois Capital Management LLC | 2.56 |
| Geode Capital Management LLC | 2.41 |
| Vanguard Total Stock Market ETF | 1.69 |
| Ayrton Capital LLC | 1.32 |
| Equitec Proprietary Markets LLC | 1.19 |
| Daniel B Asher | 1.19 |
| Sabby Management LLC | 1.18 |
| Vanguard Extended Market Index Fund | 1.08 |
| State Street Corp. | 0.90 |
| Fidelity Total Market Index Fund | 0.80 |
| Joshua Nathaniel Silverman | 0.72 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 9 | 12 | 15 | 16 | 27 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 | 1 | 1 | 2 | 85 |
| Summe Anlagevermögen | 5 | 5 | 5 | 5 | 5 |
| Summe Aktiva | 6 | 6 | 6 | 7 | 91 |
Bilanz (in Mio. USD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 | 1 | 1 | 1 | 1 |
| Summe Eigenkapital | 6 | 5 | 5 | 7 | 90 |
| Summe Passiva | 6 | 6 | 6 | 7 | 91 |